The Patent Finder

Gilgamesh Pharma, Inc.

Also on record
Records under this name other than the patents Gilgamesh Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Gilgamesh Pharma, Inc.

PatentTitleStatus Expires Confidence
17/714,879Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/973,119Novel Ergolines and Methods of Treating Mood Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/024,545Azetidinyl Tryptamines and Methods of Treating Psychiatric Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/281,127Phenalkylamines and Methods of Making and Using the Same
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/287,980Novel Ergolines and Methods of Treating Mood Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/289,476Novel Tryptamines and Methods of Treating Mood Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/294,360Methods of Treating Neuropsychiatric Disorders
Abandoned
Abandoned Oct 28, 2026
AbandonedAbandoned Oct 28, 2026
18/572,861Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/686,059Combinations of Peripheral 5-HT2A Receptor Antagonists and Central 5-HT2A Receptor Agonists
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/837,417(AMPAR-PAM)-Nmda Receptor Antagonist Combination Therapy for Treatment of Mental Conditions and Disorders
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 20 records shown.
Pro members see all 20.
Pro members: see all 20 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited